Liposomal Irinotecan + 5-FU/LV in Metastatic Pancreatic Cancer: Subgroup Analyses of Patient, Tumor, and Previous Treatment Characteristics in the Pivotal NAPOLI-1 Trial
Teresa MacArulla Mercadé, Li Tzong Chen, Chung Pin Li, Jens T. Siveke, David Cunningham, György Bodoky, Jean Frédéric Blanc, Kyung Hun Lee, Andrew Dean, Bruce Belanger, Andrea Wang-Gillam
Dive into the research topics of 'Liposomal Irinotecan + 5-FU/LV in Metastatic Pancreatic Cancer: Subgroup Analyses of Patient, Tumor, and Previous Treatment Characteristics in the Pivotal NAPOLI-1 Trial'. Together they form a unique fingerprint.